Viewing Study NCT04256434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-29 @ 11:55 AM
Study NCT ID: NCT04256434
Status: COMPLETED
Last Update Posted: 2021-11-19
First Post: 2020-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
Sponsor: Lumosa Therapeutics Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module